Company Profile

Centering on the Needs of Diagnosis and Treatment and Focusing on the Creators

Focus on early noninvasive screening of tumors

       Wuhan Ammunition Life Technology Co., Ltd.( abbreviated as "Ammunition" ) , is a high-tech  enterprise focusing on non-invasive screening and early detection products development and testing services for high incident malignant tumors worldwide. Ammunition has a complete system for the IVD R & D, manufacturing, marketing, and medical testing.
       With the concept of "early, accurate, non-invasive, home-based", the company has developed a series of early non-invasive screening products for cancers of high incidence (ICON®series). Ammunition’s massion is to decrease the incidence and mortality of cancer in China and reduce overall medical costs through the integration of early screening products and testing services.

Goal Vision

To eradicate more than 80% of tumors by early diagnosis and treatment, to reduce medical costs by 50%, so as to alleviate the poverty caused by cancer.

IColocomf® Products

IColocomf®——Early noninvasive screening for colorectal cancer

       Through extracting and detecting fecal DNA, IColocomf® can be used to find precancerous lesions and early colorectal cancer five years earlier. It can find progressive adenoma with the diameter larger than 1cm, so as to block the cancer in the pre or early stage.

Learn more

Product Advantages

Leading medical science and technology to achieve health monument

Early tumor lesions
The detection rate is higher than 90%

Highly specific to tumor
The specificity was higher than 90%

Non invasive detection
The compliance of patients is high

Self sampling at home
High privacy without need to go out of home

Product Service

Building a high tech Enterprise

结直肠癌

Colorectal cancer

Colorectal cancer is a common malignant tumor in the gastrointestinal tract. The early symptoms are not obvious. With the development of the cancer, there may be changes in defecation habits, bloody stool, diarrhea, alternating diarrhea and constipation, local abdominal pain and others, while in the late stage, the symptoms appear such as anemia, weight loss and others.

宫颈癌

Cervical cancer

Cervical cancer is one of the most common malignant tumors in women. Women with early marriage, early childbirth, multiple births and sexual disorder have a higher prevalence. There are no symptoms in the initial stage, while in the later stage abnormal vaginal bleeding might occur. It is the highest in incidence among the tumors in female genital organs and it is the most common among cancers in women. However, there is a significant regional difference in the incidence rate.

肺  癌

Lung cancer

Lung cancer is the leading cause of cancer-related death worldwide which makes it a serious health and economical problem. In addition, the 5-year survival rate is still less than 15%. Since lung cancer is mostly diagnosed at the advanced stage of disease and known therapeutic approaches are still not efficient enough, it is of particular importance to identify new biomarkers that could be used for early detection and prognosis assessment.

News

Latest news and Industry information

Good news! Ammunition won a double prize in the Star of Entrepreneurship 2020 contest!

September 16, 2020

On September 15, 2020, Ammunition Company participated in the Star of Entrepreneurship Final as scheduled. After a series of fierce competition, Ammunition achieved the first place in the Final.Fortunately, Amison also won the title of "Excellent Enterprise" in the in vitro diagnosis final of China Innovation and Entrepreneurship Competition on the same day.

View details

Nature Subjournal Liquid Biopsy - A New Noninvasive Early Detection Method for Hepatocellular Carcinoma

September 16, 2020

Recently, a Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring, published in the Journal NatureCommunications, described a method to purify extracellular vesicles (EVs) specific to hepatocellular carcinoma (HCC) using nanomatrices and detect 10 of these mRNAs for noninvasive early diagnosis of HCC.

View details

Panther lost to colorectal cancer, diarrhea, abdominal pain, hematochezia to be vigilant half-price detection of bowel cancer to save a home

September 05, 2020

Chadwick Bosman, the hero of Manway's Panther, died Friday of colon cancer at the age of 43, foreign media reported.Chadwick Bosman issued an official statement confirming that he left the world at home with his wife and family.

View details